Quantitative Assessment of Autologous Fat Transfer
Recruiting now · Not applicable
Conditions studied: Autologous Fat Grafting
In brief
This is a single-arm, prospective pilot study that will objectively assess outcomes in patients electively undergoing Autologous Fat Transfer (AFT) for breast or chest wall reconstruction. Patients planning to undergo autologous fat transfer for breast or chest wall reconstruction will be enrolled prospectively. Participants will undergo standard photographs (2-D imaging) of their chest wall and torso, including the breasts, and complete a validated questionnaire (BREAST-QTM) to evaluate patient satisfaction, and quality of life, all standard of care. The 3D photographs, Magnetic resonance imaging (MRI), and Ultrasound (US) are routinely used in practice but will be performed for research purposes in this study. All imaging procedures and questionnaires will be obtained at baseline and follow-up visits 3-6.
Key facts
- Study ID
- NCT06343831
- Run by
- University of Chicago
- People needed
- 15
- Starts
- 2024-01-25
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2025-11-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age of 18 years or older
- Planned autologous fat transfer or fat grafting reconstruction of the breast or chest wall.
- Able to provide written or electronic informed consent.
- Able to undergo MRI.
You may not qualify if…
- Vulnerable subjects (children, prisoners, pregnant women).
- Patients who have active cancer, metastatic disease, solid organ transplantation / immunosuppression, or autoimmune diseases.
- Unable to undergo MRI (history of metal contraindication, claustrophobia)
Where it is running
- The University of Chicago — Chicago, Illinois, United States (enrolling)
- The University of Houston — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.